Zurcher Kantonalbank (Zurich Cantonalbank) Gossamer Bio, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

  • $32.8 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 08, 2023
SELL
$0.96 - $2.92 $15,334 - $46,641
-15,973 Reduced 99.97%
4 $0
Q4 2022

Feb 01, 2023
BUY
$1.74 - $12.87 $5,307 - $39,253
3,050 Added 23.59%
15,977 $34,000
Q2 2022

Aug 09, 2022
SELL
$5.97 - $9.97 $1,588 - $2,652
-266 Reduced 2.02%
12,927 $108,000
Q1 2022

Apr 21, 2022
BUY
$8.44 - $12.49 $23,395 - $34,622
2,772 Added 26.6%
13,193 $115,000
Q2 2020

Jul 28, 2020
BUY
$9.52 - $15.98 $72,009 - $120,872
7,564 Added 264.75%
10,421 $135,000
Q4 2019

Jan 21, 2020
BUY
$14.82 - $26.79 $42,340 - $76,539
2,857 New
2,857 $45,000

Others Institutions Holding GOSS

# of Institutions
108
Shares Held
167M
Call Options Held
430K
Put Options Held
519K
View Full List

About Gossamer Bio, Inc.

GOSS Quotes by TradingView
  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $93M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email